SlideShare a Scribd company logo
Medicinal Chemistry
Lecture 6
Electronic Effects
• The electronic distribution in a drug molecule
has a considerable influence on the distribution
and activity of the drug.
• Once the drug reaches its site of action, the
electronic distribution will control the type of
bonds it will form with the target, which in turn
affects its biological activity.
• Quantification of the electronic effects of groups
on the physicochemical properties was first
carried out by Hammet.
The Hammet Substitution Constant
• Primarily quantifies the electronic effects of substituents
on aromatic rings.
• A measure of electron withdrawing or donating abilities
of substituents
• Has been determined by measuring the dissociation of a
series of substituted benzoic acids compared to the
dissociation of the benzoic acid itself
• Hammet substitution constants are additive.
• Table of constants that quantify inductive effect (F) and
resonance effect (R) are available.
• Substituent effect could be mainly attributed to F rather
than R or vice versa.
• A certain substituent may has a more significant effect at
a particular position.
• There are limitations to electronic effects
• There are very few drugs whose activities are solely
influenced by a substituent electronic effects
• The insecticidal activity of diethyl phenyl phosphate can
be explained by electronic effects alone
• The above constants are only valid for substituents on
aromatic rings
• But there exists a system for substituents on aliphatic
molecules
Steric Parameters
• Used to show the relationship between the shape
and size of a drug, the dimension of its drug site
and drug activity
• Taft steric parameter (Es) and molar refractivity
(MR) are the most important size parameters
The Taft Steric Parameter (Es(
• Defined on the bases of the relative rate constants of the
acid hydrolyzed α-substituted methyl ethanoates
• These rates of hydrolysis are almost entirely dependent
on steric factors
• K is the rate constant of the appropriate hydrolysis
reaction
• E = 0 when X = CH3
• It is assumed that the value of Es obtained for a group
using hydrolysis data are applicable to other structures
containing that group
• Es values are obtained by experiments (disadvantage)
• Limited number of them.
Molar Refractivity (MR(
• A measure of both the volume of the compound and how
easily it can be polarized
• Additive parameter
• n is the refractive index, MW is the molecular mass, and
P is the density of the compound, MW/P is the volume,
and the refractive index term is a measure of the
polarizability of the compound
Other physicochemical parameters
• Include: dipole moments, hydrogen bonding,
conformation and inter atomic distances.
• These are difficult to quantify. Therefore they are
much less useful in comparison with the above
parameters.
Hansch Analysis
• Attempt to mathematically relate drug activity to
measurable chemical properties
• Based on Hansch proposal:
Drug action could be divided into two stages:
1.Transport of the drug to the site of action
2.Binding of the drug to the target site
• Both stages are dependent on the chemical and physical
properties of the drug and its target site
• These properties are described by the studied
parameters
• Hansch postulated that the biological activity of the drug
could be related to these parameters by simple
mathematical relationships based on the general format:
• C is the minimum concentration needed to cause a
specific biological response, K1, K2, K3, and K4 are
numerical constants obtained by feeding the values of
the parameters selected by the investigating team into a
suitable statistical package.
• These parameter values are either obtained from the
literature (e.g. Π, σ, and Es) or determined by
experiments (C, P, etc).
• Not all parameters will necessarily be significant
• Example:
The ardegenic blocking activity of β-halo-β-arylamine:
• Accuracy of Hansch equations will depend on:
1.The number of analogues used: the greater the number
the higher the opportunity of obtaining an accurate
Hansch equation
2.The accuracy of the biological data used in the derivation
of the equation
3.The choice of the parameter
Craig Plot
• Easier way to visualize the properties of different
substituents
• Plot where the y axis is the value of σ factor and the x
axis is the value of π factor.
• The plot shows that there is no overall relationship
between σ and π.
• It is possible to tell at a glance which substituents have a
positive σ and π parameters, which substituents have a
negative σ and π, and which substituents have one
positive and one negative σ and π parameters.
• It is easy to see which substituents have a similar π
values. In theory, such substituents which will be on the
same vertical line could be interchangeable on drugs
where the principle factor affecting biological activity is
hydrophobicity.
• Groups on the same horizontal line are isoelectronic and
should be exchangable as well (e.g. Cl, Br, I)
• The Craig plot is useful in planning which substituents to
use in QSAR studies. For example:
1. halide substituents (increased hydrophobicity and
electron withdrawing activity, positive σ and positive π)
2. OH (increased hydrophilicity and electron donating
properties, negative σ and negative π)
3. Alkyl groups (positive π and negative σ)
4. Acyl groups (negative π and positive σ)
• Once the Hansch equation is derived it will show
whether π or σ should be positive or negative in order to
obtain the desired biological activity.
• Further developments would then concentrate on
substituents from a certain quadrant. For example:
Positive π and σ values in Hansch equation means that
we should focus on the top right quadrant.
What is next?
• Receptors and receptor sites

More Related Content

What's hot

PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTPHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
Shikha Popali
 
QSAR by hansch analysis
QSAR by hansch analysisQSAR by hansch analysis
QSAR by hansch analysis
kholood adil
 
IMPURITIES IN API’s INCLUDING GENOTOXIC IMPURITIES.pptx
IMPURITIES IN API’s INCLUDING GENOTOXIC IMPURITIES.pptxIMPURITIES IN API’s INCLUDING GENOTOXIC IMPURITIES.pptx
IMPURITIES IN API’s INCLUDING GENOTOXIC IMPURITIES.pptx
PurushothamKN1
 
Mass spectroscopy (advanced spectral analysis)
Mass spectroscopy (advanced spectral analysis)Mass spectroscopy (advanced spectral analysis)
Mass spectroscopy (advanced spectral analysis)
MAYANK ,MEHENDIRATTA
 
Process chemistry
Process chemistryProcess chemistry
Process chemistry
Shikha Popali
 
continuous flow reactor M.Pharm .pptx
continuous flow reactor M.Pharm .pptxcontinuous flow reactor M.Pharm .pptx
continuous flow reactor M.Pharm .pptx
Kartik Tiwari
 
QSAR
QSARQSAR
Molecular and Quantum Mechanics in drug design
Molecular and Quantum Mechanics in drug designMolecular and Quantum Mechanics in drug design
Molecular and Quantum Mechanics in drug design
Ajay Kumar
 
Process chemistry AS PER PCI SYLLABUS FOR M.PHARM
Process chemistry AS PER PCI SYLLABUS FOR M.PHARMProcess chemistry AS PER PCI SYLLABUS FOR M.PHARM
Process chemistry AS PER PCI SYLLABUS FOR M.PHARM
Shikha Popali
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSAR
RaniBhagat1
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysis
KomalJAIN122
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysis
ASHOK GAUTAM
 
3d qsar
3d qsar3d qsar
3d qsar
Mahendra G S
 
Mass fragmentation & rules
Mass fragmentation & rulesMass fragmentation & rules
Mass fragmentation & rules
MehulJain143
 
Stages of scale up process mparm 1st year pharmaceutical process chemistry
Stages of scale up process mparm 1st year pharmaceutical process chemistryStages of scale up process mparm 1st year pharmaceutical process chemistry
Stages of scale up process mparm 1st year pharmaceutical process chemistry
DhanashreeSarwan
 
3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
Baddi University of Emerging sciences and Technology
 
LC-FTIR
LC-FTIRLC-FTIR
Lecture 6
Lecture 6Lecture 6
Lecture 6
ammar905
 
3D QSAR
3D QSAR3D QSAR
3D QSAR
suraj wanjari
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screening
Joon Jyoti Sahariah
 

What's hot (20)

PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTPHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
 
QSAR by hansch analysis
QSAR by hansch analysisQSAR by hansch analysis
QSAR by hansch analysis
 
IMPURITIES IN API’s INCLUDING GENOTOXIC IMPURITIES.pptx
IMPURITIES IN API’s INCLUDING GENOTOXIC IMPURITIES.pptxIMPURITIES IN API’s INCLUDING GENOTOXIC IMPURITIES.pptx
IMPURITIES IN API’s INCLUDING GENOTOXIC IMPURITIES.pptx
 
Mass spectroscopy (advanced spectral analysis)
Mass spectroscopy (advanced spectral analysis)Mass spectroscopy (advanced spectral analysis)
Mass spectroscopy (advanced spectral analysis)
 
Process chemistry
Process chemistryProcess chemistry
Process chemistry
 
continuous flow reactor M.Pharm .pptx
continuous flow reactor M.Pharm .pptxcontinuous flow reactor M.Pharm .pptx
continuous flow reactor M.Pharm .pptx
 
QSAR
QSARQSAR
QSAR
 
Molecular and Quantum Mechanics in drug design
Molecular and Quantum Mechanics in drug designMolecular and Quantum Mechanics in drug design
Molecular and Quantum Mechanics in drug design
 
Process chemistry AS PER PCI SYLLABUS FOR M.PHARM
Process chemistry AS PER PCI SYLLABUS FOR M.PHARMProcess chemistry AS PER PCI SYLLABUS FOR M.PHARM
Process chemistry AS PER PCI SYLLABUS FOR M.PHARM
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSAR
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysis
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysis
 
3d qsar
3d qsar3d qsar
3d qsar
 
Mass fragmentation & rules
Mass fragmentation & rulesMass fragmentation & rules
Mass fragmentation & rules
 
Stages of scale up process mparm 1st year pharmaceutical process chemistry
Stages of scale up process mparm 1st year pharmaceutical process chemistryStages of scale up process mparm 1st year pharmaceutical process chemistry
Stages of scale up process mparm 1st year pharmaceutical process chemistry
 
3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
 
LC-FTIR
LC-FTIRLC-FTIR
LC-FTIR
 
Lecture 6
Lecture 6Lecture 6
Lecture 6
 
3D QSAR
3D QSAR3D QSAR
3D QSAR
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screening
 

Similar to Lecture6 100717171815-phpapp01

QSAR
QSARQSAR
Principles and Applications of Structure Activity Relationship
Principles and Applications of Structure Activity RelationshipPrinciples and Applications of Structure Activity Relationship
Principles and Applications of Structure Activity Relationship
Nizam Ashraf
 
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR
QSARQSAR
Qsar parameter
Qsar parameterQsar parameter
Qsar parameter
sharad patange
 
QSAR (Quantitative Structural Activity Relationship)
QSAR (Quantitative Structural Activity Relationship)QSAR (Quantitative Structural Activity Relationship)
QSAR (Quantitative Structural Activity Relationship)
Richa Tripathy
 
Quantitative structure - activity relationship (QSAR)
Quantitative  structure - activity  relationship (QSAR)Quantitative  structure - activity  relationship (QSAR)
Quantitative structure - activity relationship (QSAR)
Eswaran Murugesan
 
Qsar parameters by ranjeeth k
Qsar parameters by ranjeeth kQsar parameters by ranjeeth k
Qsar parameters by ranjeeth k
RanjeethK2
 
Ashish(qsar)
Ashish(qsar)Ashish(qsar)
Ashish(qsar)
Chandrika Mourya
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
bhavnesh munjal
 
Ligand based drug design
Ligand based drug designLigand based drug design
Ligand based drug design
Satyendra Yadav
 
QSAR Studies presentation
 QSAR Studies presentation QSAR Studies presentation
QSAR Studies presentation
Ashruti agrawal
 
Physicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdfPhysicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdf
RAJ K. MAURYA
 
SAR of Morphine
SAR of MorphineSAR of Morphine
SAR of Morphine
Nabiilah Naraino Majie
 
Qsar UMA
Qsar   UMAQsar   UMA
Qsar UMA
Uma Bansal
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug Design
Sagar Magar
 
Lecture 5
Lecture 5Lecture 5
Lecture 5
ammar905
 
Quantitative structure activity relationships
Quantitative structure activity relationshipsQuantitative structure activity relationships
Quantitative structure activity relationships
Shilpa Harak
 
Quantitative structure activity relationships
Quantitative structure  activity relationshipsQuantitative structure  activity relationships
Quantitative structure activity relationships
Amiya ghosh
 

Similar to Lecture6 100717171815-phpapp01 (20)

QSAR
QSARQSAR
QSAR
 
Principles and Applications of Structure Activity Relationship
Principles and Applications of Structure Activity RelationshipPrinciples and Applications of Structure Activity Relationship
Principles and Applications of Structure Activity Relationship
 
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR.pptx
 
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR.pptx
 
QSAR
QSARQSAR
QSAR
 
Qsar parameter
Qsar parameterQsar parameter
Qsar parameter
 
QSAR (Quantitative Structural Activity Relationship)
QSAR (Quantitative Structural Activity Relationship)QSAR (Quantitative Structural Activity Relationship)
QSAR (Quantitative Structural Activity Relationship)
 
Quantitative structure - activity relationship (QSAR)
Quantitative  structure - activity  relationship (QSAR)Quantitative  structure - activity  relationship (QSAR)
Quantitative structure - activity relationship (QSAR)
 
Qsar parameters by ranjeeth k
Qsar parameters by ranjeeth kQsar parameters by ranjeeth k
Qsar parameters by ranjeeth k
 
Ashish(qsar)
Ashish(qsar)Ashish(qsar)
Ashish(qsar)
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
Ligand based drug design
Ligand based drug designLigand based drug design
Ligand based drug design
 
QSAR Studies presentation
 QSAR Studies presentation QSAR Studies presentation
QSAR Studies presentation
 
Physicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdfPhysicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdf
 
SAR of Morphine
SAR of MorphineSAR of Morphine
SAR of Morphine
 
Qsar UMA
Qsar   UMAQsar   UMA
Qsar UMA
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug Design
 
Lecture 5
Lecture 5Lecture 5
Lecture 5
 
Quantitative structure activity relationships
Quantitative structure activity relationshipsQuantitative structure activity relationships
Quantitative structure activity relationships
 
Quantitative structure activity relationships
Quantitative structure  activity relationshipsQuantitative structure  activity relationships
Quantitative structure activity relationships
 

More from Cleophas Rwemera

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891
Cleophas Rwemera
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892
Cleophas Rwemera
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892
Cleophas Rwemera
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01
Cleophas Rwemera
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02
Cleophas Rwemera
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02
Cleophas Rwemera
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Cleophas Rwemera
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Cleophas Rwemera
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Cleophas Rwemera
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Cleophas Rwemera
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Cleophas Rwemera
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Cleophas Rwemera
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Cleophas Rwemera
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Cleophas Rwemera
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Cleophas Rwemera
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Cleophas Rwemera
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01
Cleophas Rwemera
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Cleophas Rwemera
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02
Cleophas Rwemera
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Cleophas Rwemera
 

More from Cleophas Rwemera (20)

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
 

Recently uploaded

Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptxPrésentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
siemaillard
 
Electric Fetus - Record Store Scavenger Hunt
Electric Fetus - Record Store Scavenger HuntElectric Fetus - Record Store Scavenger Hunt
Electric Fetus - Record Store Scavenger Hunt
RamseyBerglund
 
Stack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 MicroprocessorStack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 Microprocessor
JomonJoseph58
 
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxBeyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
EduSkills OECD
 
Geography as a Discipline Chapter 1 __ Class 11 Geography NCERT _ Class Notes...
Geography as a Discipline Chapter 1 __ Class 11 Geography NCERT _ Class Notes...Geography as a Discipline Chapter 1 __ Class 11 Geography NCERT _ Class Notes...
Geography as a Discipline Chapter 1 __ Class 11 Geography NCERT _ Class Notes...
ImMuslim
 
Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"
National Information Standards Organization (NISO)
 
How Barcodes Can Be Leveraged Within Odoo 17
How Barcodes Can Be Leveraged Within Odoo 17How Barcodes Can Be Leveraged Within Odoo 17
How Barcodes Can Be Leveraged Within Odoo 17
Celine George
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
iammrhaywood
 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
PsychoTech Services
 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Henry Hollis
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
Steve Thomason
 
Nutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour TrainingNutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour Training
melliereed
 
MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025
khuleseema60
 
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptxRESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
zuzanka
 
Bossa N’ Roll Records by Ismael Vazquez.
Bossa N’ Roll Records by Ismael Vazquez.Bossa N’ Roll Records by Ismael Vazquez.
Bossa N’ Roll Records by Ismael Vazquez.
IsmaelVazquez38
 
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptxBIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
RidwanHassanYusuf
 
HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.
deepaannamalai16
 
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
National Information Standards Organization (NISO)
 
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Himanshu Rai
 
How to deliver Powerpoint Presentations.pptx
How to deliver Powerpoint  Presentations.pptxHow to deliver Powerpoint  Presentations.pptx
How to deliver Powerpoint Presentations.pptx
HajraNaeem15
 

Recently uploaded (20)

Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptxPrésentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
 
Electric Fetus - Record Store Scavenger Hunt
Electric Fetus - Record Store Scavenger HuntElectric Fetus - Record Store Scavenger Hunt
Electric Fetus - Record Store Scavenger Hunt
 
Stack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 MicroprocessorStack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 Microprocessor
 
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxBeyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
 
Geography as a Discipline Chapter 1 __ Class 11 Geography NCERT _ Class Notes...
Geography as a Discipline Chapter 1 __ Class 11 Geography NCERT _ Class Notes...Geography as a Discipline Chapter 1 __ Class 11 Geography NCERT _ Class Notes...
Geography as a Discipline Chapter 1 __ Class 11 Geography NCERT _ Class Notes...
 
Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"
 
How Barcodes Can Be Leveraged Within Odoo 17
How Barcodes Can Be Leveraged Within Odoo 17How Barcodes Can Be Leveraged Within Odoo 17
How Barcodes Can Be Leveraged Within Odoo 17
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
 
Nutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour TrainingNutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour Training
 
MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025
 
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptxRESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
 
Bossa N’ Roll Records by Ismael Vazquez.
Bossa N’ Roll Records by Ismael Vazquez.Bossa N’ Roll Records by Ismael Vazquez.
Bossa N’ Roll Records by Ismael Vazquez.
 
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptxBIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
 
HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.
 
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
 
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
 
How to deliver Powerpoint Presentations.pptx
How to deliver Powerpoint  Presentations.pptxHow to deliver Powerpoint  Presentations.pptx
How to deliver Powerpoint Presentations.pptx
 

Lecture6 100717171815-phpapp01

  • 2. Electronic Effects • The electronic distribution in a drug molecule has a considerable influence on the distribution and activity of the drug. • Once the drug reaches its site of action, the electronic distribution will control the type of bonds it will form with the target, which in turn affects its biological activity. • Quantification of the electronic effects of groups on the physicochemical properties was first carried out by Hammet.
  • 3. The Hammet Substitution Constant • Primarily quantifies the electronic effects of substituents on aromatic rings. • A measure of electron withdrawing or donating abilities of substituents • Has been determined by measuring the dissociation of a series of substituted benzoic acids compared to the dissociation of the benzoic acid itself • Hammet substitution constants are additive.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. • Table of constants that quantify inductive effect (F) and resonance effect (R) are available. • Substituent effect could be mainly attributed to F rather than R or vice versa. • A certain substituent may has a more significant effect at a particular position. • There are limitations to electronic effects • There are very few drugs whose activities are solely influenced by a substituent electronic effects
  • 9. • The insecticidal activity of diethyl phenyl phosphate can be explained by electronic effects alone
  • 10. • The above constants are only valid for substituents on aromatic rings • But there exists a system for substituents on aliphatic molecules
  • 11.
  • 12. Steric Parameters • Used to show the relationship between the shape and size of a drug, the dimension of its drug site and drug activity • Taft steric parameter (Es) and molar refractivity (MR) are the most important size parameters
  • 13. The Taft Steric Parameter (Es( • Defined on the bases of the relative rate constants of the acid hydrolyzed α-substituted methyl ethanoates • These rates of hydrolysis are almost entirely dependent on steric factors
  • 14. • K is the rate constant of the appropriate hydrolysis reaction • E = 0 when X = CH3 • It is assumed that the value of Es obtained for a group using hydrolysis data are applicable to other structures containing that group • Es values are obtained by experiments (disadvantage) • Limited number of them.
  • 15.
  • 16. Molar Refractivity (MR( • A measure of both the volume of the compound and how easily it can be polarized • Additive parameter
  • 17. • n is the refractive index, MW is the molecular mass, and P is the density of the compound, MW/P is the volume, and the refractive index term is a measure of the polarizability of the compound
  • 18. Other physicochemical parameters • Include: dipole moments, hydrogen bonding, conformation and inter atomic distances. • These are difficult to quantify. Therefore they are much less useful in comparison with the above parameters.
  • 19. Hansch Analysis • Attempt to mathematically relate drug activity to measurable chemical properties • Based on Hansch proposal: Drug action could be divided into two stages: 1.Transport of the drug to the site of action 2.Binding of the drug to the target site • Both stages are dependent on the chemical and physical properties of the drug and its target site • These properties are described by the studied parameters
  • 20. • Hansch postulated that the biological activity of the drug could be related to these parameters by simple mathematical relationships based on the general format:
  • 21. • C is the minimum concentration needed to cause a specific biological response, K1, K2, K3, and K4 are numerical constants obtained by feeding the values of the parameters selected by the investigating team into a suitable statistical package. • These parameter values are either obtained from the literature (e.g. Π, σ, and Es) or determined by experiments (C, P, etc).
  • 22. • Not all parameters will necessarily be significant • Example: The ardegenic blocking activity of β-halo-β-arylamine:
  • 23.
  • 24. • Accuracy of Hansch equations will depend on: 1.The number of analogues used: the greater the number the higher the opportunity of obtaining an accurate Hansch equation 2.The accuracy of the biological data used in the derivation of the equation 3.The choice of the parameter
  • 25. Craig Plot • Easier way to visualize the properties of different substituents • Plot where the y axis is the value of σ factor and the x axis is the value of π factor.
  • 26.
  • 27. • The plot shows that there is no overall relationship between σ and π. • It is possible to tell at a glance which substituents have a positive σ and π parameters, which substituents have a negative σ and π, and which substituents have one positive and one negative σ and π parameters. • It is easy to see which substituents have a similar π values. In theory, such substituents which will be on the same vertical line could be interchangeable on drugs where the principle factor affecting biological activity is hydrophobicity.
  • 28. • Groups on the same horizontal line are isoelectronic and should be exchangable as well (e.g. Cl, Br, I) • The Craig plot is useful in planning which substituents to use in QSAR studies. For example: 1. halide substituents (increased hydrophobicity and electron withdrawing activity, positive σ and positive π) 2. OH (increased hydrophilicity and electron donating properties, negative σ and negative π) 3. Alkyl groups (positive π and negative σ) 4. Acyl groups (negative π and positive σ)
  • 29. • Once the Hansch equation is derived it will show whether π or σ should be positive or negative in order to obtain the desired biological activity. • Further developments would then concentrate on substituents from a certain quadrant. For example: Positive π and σ values in Hansch equation means that we should focus on the top right quadrant.
  • 30. What is next? • Receptors and receptor sites